Rules 4.7.3 and 4.10.3 ASX Listing Rules Appendix 4G (current at 17/7/2020) Page 1 Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations Name of entity Optiscan Imaging Limited ABN/ARBN Financial year ended: 81 077 771 987 30 June 2026 ...
Appendix 4G & Corporate Governance Statement
Filed with ASX ·
6ix hasn’t read this filing yet.
Optiscan Imaging Limited on 6ix
Earlier from Optiscan Imaging
- 2026 Annual Report
- Quarterly Activities/Appendix 4C Cash Flow Report
- Optiscan Signs New Research Agreement for Breast Study
- Head and Neck Study Progressing Ahead of Schedule
- Optiscan Launches InSpecta Device for Veterinary Medicine
Later from Optiscan Imaging
- Preliminary Final Report
- Optiscan Initiates Head and Neck Cancer Study in the US
- Change of Director's Interest Notice
- Application for quotation of securities - OIL
- Significant Milestone Reached in ACL Digital Pathology Study
Follow Optiscan Imaging into a list and get an email when it puts out news.
Follow Optiscan Imaging